Cargando…
Titrating lovaza from 4 to 8 to 12 grams/day in patients with primary hypertriglyceridemia who had triglyceride levels >500 mg/dl despite conventional triglyceride lowering therapy
BACKGROUND: Omega-3 fatty acids are important in treatment of severe primary hypertriglyceridemia (HTG). In 15 patients with severe primary HTG (TG >500 mg/dl despite conventional TG lowering therapy), we assessed efficacy-safety of sequential monthly treatment with Lovaza, 4 to 8 to 12 g/day. ME...
Autores principales: | Glueck, Charles J, Khan, Naseer, Riaz, Muhammad, Padda, Jagjit, Khan, Zia, Wang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551656/ https://www.ncbi.nlm.nih.gov/pubmed/23110706 http://dx.doi.org/10.1186/1476-511X-11-143 |
Ejemplares similares
-
Effects of different triglyceride-lowering therapies in patients with hypertriglyceridemia-induced acute pancreatitis
por: Yu, Shanshan, et al.
Publicado: (2020) -
Prevalence of US Adults with Triglycerides ≥ 150 mg/dl: NHANES 2007–2014
por: Fan, Wenjun, et al.
Publicado: (2020) -
Inhibition of Angiopoietin-Like Protein 3 With a Monoclonal Antibody Reduces Triglycerides in Hypertriglyceridemia
por: Ahmad, Zahid, et al.
Publicado: (2019) -
Large triglyceride-rich lipoproteins in hypertriglyceridemia are associated with the severity of acute pancreatitis in experimental mice
por: Zhang, Yue, et al.
Publicado: (2019) -
Calculated Non-HDL Cholesterol Includes Cholesterol in Larger Triglyceride-Rich Lipoproteins in Hypertriglyceridemia
por: Sun, Cathy J, et al.
Publicado: (2019)